Contact Us
Find A Doctor

Neovascular Age-Related Macular Degeneration

Principal Investigator

Richard Rosen, MD

Enrollment Status

Completed

Objective

To assess the efficacy of intravitreal (ITV) administered VEGF Trap compared to Lucentis (ranibizumab) in a non-inferiority paradigm in preventing moderate vision loss in subjects with all subtypes of neovascular AMD.

 

 

 

Contact Us

Dr. Richard Rosen, Principal InvestigatorTel: (212) 979-4284

Katy Tai, Research ManagerTel: (212) 979-4251

Address310 E. 14th StreetNew York, NY 10003

View all locations